secwatch.observer — SEC 8-K summary
======================================

Issuer:     Terns Pharmaceuticals, Inc. (TERN)
CIK:        0001831363
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0000950170-23-022264
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Terns Pharmaceuticals enters $150M ATM equity offering with Cowen
-----------------------------------------------------------------

- Up to $150M of common stock may be sold at-the-market through sales agent Cowen.
- Cowen receives up to 3.0% of gross proceeds from shares sold under the agreement.
- Sales may be made on Nasdaq or as principal; either party can suspend the offering.
- Shares offered under existing shelf registration statement on Form S-3 effective Feb 10, 2023.
- Legal opinion from Wilmer Cutler Pickering Hale and Dorr LLP included as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831363/000095017023022264/0000950170-23-022264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831363/000095017023022264/tern-20230515.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-022264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer